This phenotype is characterized by typical signs and symptoms of heart failure in the presence of an elevated cardiac index (>3.9 L/min/m2) and increased circulating biomarkers, particularly brain natriuretic peptide (BNP) (9). This evidence concerns the gene NPPB and heart failure.